GlassScriptPhysician profile
Brian K Lentz
NPI 1770535163
$6,650.93
in general payments reported to CMS, 2019-2025
37 companies · $766 in 2025
The $766 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,171 · 2020: $1,395 · 2021: $120 · 2022: $310 · 2023: $459 · 2024: $431 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.10 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,554.76 | 2019-2025 | Diamondback Coronary |
| Amgen INC. | $648.79 | 2019-2020 | |
| Shockwave Medical, INC | $619.90 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $489.68 | 2019-2024 | Avvigo Guidance System, Rotapro |
| Abiomed | $485.31 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $372.09 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $293.35 | 2019-2021 | |
| Cardiovascular Systems INC. | $216.62 | 2019-2022 | |
| Pfizer INC. | $204.67 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $190.05 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.87 | 2019-2021 | |
| Chiesi USA, INC. | $151.05 | 2020-2024 | Kengreal, Cleviprex |
| Vital Connect, INC | $117.16 | 2023 | Vitalpatch Rtm |
| Zoll Circulation INC | $116.42 | 2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Regeneron Healthcare Solutions, INC. | $108.44 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $101.49 | 2019-2020 | |
| Medtronic Vascular, INC. | $98.59 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.45 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $78.07 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $71.91 | 2019 | |
| Portola Pharmaceuticals, LLC | $53.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $46.30 | 2019-2020 | |
| Medtronic, INC. | $45.37 | 2024-2025 | Symplicity G3 |
| Gilead Sciences, INC. | $42.23 | 2019 | |
| Livanova USA, INC. | $41.00 | 2020 | |
| Irhythm Technologies, INC. | $38.85 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $34.41 | 2021 | |
| Akcea Therapeutics, INC. | $32.88 | 2020 | |
| Teleflex LLC | $31.01 | 2019-2023 | Guardian |
| Cardiva Medical, INC. | $22.48 | 2019 | |
| Welch Allyn | $18.00 | 2019 | |
| Lundbeck LLC | $17.68 | 2020 | |
| Nuwellis, INC. | $17.42 | 2019 | |
| Esperion Therapeutics, INC. | $14.09 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.47 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.54 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lentz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.